MOLECULAR PARTNERS AG
MOLECULAR PARTNERS AG
Acción · CH0256379097 · A12DEH (XSWX)
Resumen Indicadores financieros
3,05 CHF
-1,53 % -0,05 CHF
SIX (XLON) · Precios actuales y gráficos en MoneyPeak
13.06.2025 09:40

Cotizaciones actuales de MOLECULAR PARTNERS AG

BolsaTickerMonedaÚltima operaciónPrecioVariación diaria
XLON: London
London
0QXX.L
CHF
13.06.2025 09:40
3,05 CHF
3,10 CHF
-1,53 %

Rendimiento

Día Semana Mes 3 meses 6 meses 1 año 5 años
-1,53 % 2,26 % -12,03 % -16,83 % -38,27 % -54,17 % -54,17 %

Perfil de la empresa para MOLECULAR PARTNERS AG Acción

Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, as well as for diabetic macular edema; and MP0420, a multi-specific DARPin therapeutic candidate for the SARS-CoV-2 virus. The company develops MP0310, which is in Phase Ia clinical trials for immuno-oncology; MP0317, a tumor-localized immune agonist that activates immune cells in the tumor, which is in Phase I clinical trials; and MP0274 that is in Phase I clinical trials for HER2-positive cancers. It also develops MP0423 for treating COVID-19; MP0533, a CD3 T cell candidate for acute myeloid leukemia; and MP0250 for vascular endothelial growth factor, hepatocyte growth factor, and human serum albumin to increase half-life. Molecular Partners AG has agreements and collaboration with Novartis AG to develop, manufacture, and commercialize DARPin-conjugated radioligand therapies; Amgen SA; Allergan, Inc.; and discovery alliance with AbbVie Inc. in ophthalmology, as well as other third-party collaborators. The company was incorporated in 2004 and is headquartered in Schlieren, Switzerland.

Datos de la empresa

Nombre MOLECULAR PARTNERS AG
Empresa Molecular Partners AG
Sitio web https://www.molecularpartners.com
Mercado principal XSWX SIX
WKN A12DEH
ISIN CH0256379097
Tipo de valor Acción
Sector Healthcare
Industria Medical - Pharmaceuticals
CEO Dr. Patrick Amstutz Ph.D.
Capitalización de mercado 132 Mio
País Suiza
Moneda CHF
Empleados 0,2 T
Dirección Wagistrasse 14, 8952 Schlieren
Fecha de OPV 2014-11-05

Símbolos de cotización

Nombre Símbolo
Frankfurt 6ML.F
London 0QXX.L

Otras acciones

Los inversores que tienen MOLECULAR PARTNERS AG también tienen las siguientes acciones en su cartera:
CARL ZEISS MEDITEC AG
CARL ZEISS MEDITEC AG Acción
ISHARES MSCI WORLD GBP HEDGED
ISHARES MSCI WORLD GBP HEDGED ETF
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras. Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Aviso legal Protección de datos Blog Comunidad Comentarios Changelog
Im App Store herunterladen Bei Google Play herunterladen
Todos los derechos reservados © LCP GmbH 2025